Locke Eric, Heroux-Legault Roxane, Alothman Maram, Jibri Zaid, Meulenkamp Brad, Lalonde Karl-André
Division of Orthopaedic Surgery, University of Ottawa, Ottawa, ON, Canada.
Department of Radiology, University of Ottawa, Ottawa, ON, Canada.
Foot Ankle Orthop. 2025 Aug 29;10(3):24730114251363495. doi: 10.1177/24730114251363495. eCollection 2025 Jul.
Total ankle replacement (TAR) is a surgical option for patients with ankle arthritis who have failed conservative measures. Newer implants have markedly improved; however, osteolysis causing aseptic loosening continues to be a main cause of TAR failure. The objective of this study was to review the HINTEGRA TAR experience at a single institution specifically evaluating the presence and outcomes of osteolysis.
Retrospective study including all HINTEGRA TARs completed by 1 experienced foot and ankle surgeon from 2006 to 2014. Radiographs were reviewed, assessing for implant positioning, presence, location, and progression of cysts as well as relationship between osteolysis with reoperations and revisions.
Fifty-one TARs were identified with radiographic follow-up of 5.8 ± 3.5 years. Eighty-four cysts were detected in 37 patients, with increasing number and size of cysts being correlated to length of time from surgery. The most common location was the posterior tibia. Thirteen patients had enlarging cysts identified over time, with the lateral malleolus being the most common location. Seven patients met criteria for malaligned prosthesis, 12 patients required a reoperation, and 2 patients experienced implant failure.
Osteolysis is a very common finding after TAR using the HINTEGRA prosthesis, specifically on long-term radiographic follow-up. Progressive cysts and prosthesis coronal malalignment appear to be risk factors for developing osteolysis, prosthesis loosening, and reoperation. Most cysts did not result in clinical failure, but progressive lesions identified beyond 1 year warrant closer monitoring. This study also shows excellent and reliable outcomes of the HINTEGRA TAR compared with designer surgeons with acceptable complication and revision rates.
Level IV, Case series.
对于保守治疗失败的踝关节炎患者,全踝关节置换术(TAR)是一种手术选择。新型植入物有了显著改进;然而,导致无菌性松动的骨溶解仍是TAR失败的主要原因。本研究的目的是回顾单一机构使用HINTEGRA全踝关节置换术的经验,特别评估骨溶解的存在情况及结果。
回顾性研究纳入了2006年至2014年由1名经验丰富的足踝外科医生完成的所有HINTEGRA全踝关节置换术病例。对X线片进行评估,观察植入物位置、囊肿的存在、位置、进展情况以及骨溶解与再次手术和翻修之间的关系。
共确定51例全踝关节置换术病例,X线片随访时间为5.8±3.5年。在37例患者中检测到84个囊肿,囊肿数量和大小的增加与手术时间长短相关。最常见的位置是胫骨后侧。随着时间推移,13例患者的囊肿增大,最常见的位置是外踝。7例患者符合假体排列不齐标准,12例患者需要再次手术,2例患者出现植入物失败。
使用HINTEGRA假体进行全踝关节置换术后,骨溶解是非常常见的现象,尤其是在长期X线片随访中。进展性囊肿和假体冠状面排列不齐似乎是发生骨溶解、假体松动和再次手术的危险因素。大多数囊肿并未导致临床失败,但术后1年以上发现的进展性病变需要密切监测。与其他外科医生相比,本研究还显示HINTEGRA全踝关节置换术具有良好且可靠的结果,并发症和翻修率可接受。
IV级,病例系列研究。